Clinical Roundup Combination targeted treatment produces lasting remissions in resistant aggressive DLBCL in phase Ib/II study June 21, 2024Vol.50 No.25
Clinical Roundup Oncology drugs approved post-2020 more likely to include postmarketing approaches to collecting data in underrepresented populations June 21, 2024Vol.50 No.25
Clinical Roundup NLRC5 is an innate immune sensor that plays a crucial role in PANoptotic cell death June 21, 2024Vol.50 No.25
Clinical Roundup CAR NK cells with CD28 costimulation improved cell persistence, antitumor activity June 21, 2024Vol.50 No.25
Clinical Roundup Fewer than 20% of U.S. adults eligible for lung cancer screening comply with USPSTF guideline June 14, 2024Vol.50 No.24
Clinical Roundup Cost-of-care discussions rarely documented for patients with advanced cancer June 14, 2024Vol.50 No.24
Clinical Roundup AI tool helps to diagnose and predict severity of lung cancers June 14, 2024Vol.50 No.24
Clinical Roundup AI improves physicians’ ability to identify prostate cancer extent June 14, 2024Vol.50 No.24
Clinical Roundup AI-based blood test outperforms ultrasound in early liver cancer detection June 14, 2024Vol.50 No.24
